Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Bain Capital Specialty Finance Inc. (BCSF) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Asset Management
$12.85
+0.06 (0.47%)Did BCSF Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Bain Capital Specialty Finance is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, BCSF has a neutral consensus with a median price target of $13.50 (ranging from $13.00 to $15.00). The overall analyst rating is Buy (6.7/10). Currently trading at $12.85, the median forecast implies a 5.1% upside. This outlook is supported by 1 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Paul Johnson at Keefe, Bruyette & Woods, projecting a 16.7% upside. Conversely, the most conservative target is provided by Finian O'Shea at Wells Fargo, suggesting a 1.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for BCSF.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 3, 2026 | Keefe, Bruyette & Woods | Paul Johnson | Outperform | Maintains | $15.00 |
| Mar 3, 2026 | Wells Fargo | Finian O'Shea | Equal-Weight | Maintains | $13.00 |
| Jan 7, 2026 | Wells Fargo | Equal-Weight | Downgrade | $N/A | |
| Dec 19, 2025 | Keefe, Bruyette & Woods | Outperform | Upgrade | $N/A | |
| Nov 13, 2025 | Keefe, Bruyette & Woods | Market Perform | Maintains | $N/A | |
| Nov 12, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Apr 28, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Apr 8, 2025 | Keefe, Bruyette & Woods | Market Perform | Maintains | $N/A | |
| Mar 4, 2025 | Keefe, Bruyette & Woods | Market Perform | Maintains | $N/A | |
| Mar 3, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Jan 29, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Aug 21, 2024 | Keefe, Bruyette & Woods | Market Perform | Maintains | $N/A | |
| Aug 8, 2024 | Wells Fargo | Overweight | Maintains | $N/A | |
| Jul 26, 2024 | Wells Fargo | Overweight | Maintains | $N/A | |
| May 29, 2024 | Wells Fargo | Overweight | Upgrade | $N/A | |
| May 23, 2024 | Keefe, Bruyette & Woods | Market Perform | Maintains | $N/A | |
| May 8, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Jan 29, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Aug 10, 2023 | Citigroup | Neutral | Maintains | $N/A | |
| Aug 10, 2023 | Wells Fargo | Equal-Weight | Maintains | $N/A |
The following stocks are similar to Bain Capital Specialty Finance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Bain Capital Specialty Finance Inc. has a market capitalization of $829.67M with a P/E ratio of 11.2x. The company generates $272.58M in trailing twelve-month revenue with a 27.0% profit margin.
Revenue growth is -1.0% quarter-over-quarter, while maintaining an operating margin of +73.3% and return on equity of +6.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides financing solutions for middle-market companies.
The company operates as a business development company, specializing in direct lending through senior, unitranche, mezzanine debt, and equity investments. It generates revenue by offering tailored financing solutions that support business expansions, acquisitions, and refinancings, enabling mid-sized enterprises to access capital that traditional banks may overlook.
Bain Capital Specialty Finance Inc. leverages the expertise and network of Bain Capital, allowing it to identify lucrative investment opportunities. The company is positioned as a significant player in the specialty finance market, focusing on rigorous due diligence and strategic risk management to enhance operational efficiency for its clients.
Financial Services
Asset Management
0
Mr. Michael Alexander Ewald
United States
2018
Bain Capital Specialty (BCSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bain Capital Specialty (BCSF) has been upgraded to a Zacks Rank #2 (Buy), indicating growing optimism about its earnings prospects, which may drive its stock higher.
Bain Capital Specialty's Zacks Rank upgrade signals increased earnings potential, suggesting potential stock price appreciation and attracting investor interest.
Bain Capital Specialty Finance is trading at a 22% discount to NAV, offering a 12.7% dividend yield, though NII coverage of the dividend has fallen to 100%.
Bain Capital Specialty Finance's significant discount to NAV and high dividend yield attract attention, but declining NII coverage raises concerns about sustainability of the dividend.
Investors should exercise caution when using basic websites for dividend research, as the information may not be reliable or accurate.
Reliance on unverified sources for dividend research can lead to poor investment decisions, affecting portfolio performance and risk management.
Bain Capital Specialty Finance (NYSE: BCSF) reported Q1 net investment income matching its dividend, but net income was affected by unrealized losses and market valuation changes.
BCSF's net investment income matching its dividend indicates stability, but unrealized losses raise concerns about portfolio health and market conditions, potentially affecting future earnings and dividends.
Bain Capital Specialty Finance, Inc. (BCSF) held its Q1 2026 earnings call, discussing financial performance and strategic updates. Further details are available in the transcript.
The Q1 2026 earnings call provides insights into BCSF's financial performance, potential growth, and strategy, influencing investor sentiment and stock valuation.
Bain Capital Specialty Finance, Inc. (NYSE: BCSF) reported stable financial results for Q1 2026 and declared a dividend of $0.42 per share for Q2 2026, citing solid credit fundamentals.
Bain Capital Specialty Finance's stable credit fundamentals and consistent dividend indicate financial health, potentially attracting investors seeking reliable income and growth opportunities.
Based on our analysis of 3 Wall Street analysts, Bain Capital Specialty Finance Inc. (BCSF) has a median price target of $13.50. The highest price target is $15.00 and the lowest is $13.00.
According to current analyst ratings, BCSF has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $12.85. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict BCSF stock could reach $13.50 in the next 12 months. This represents a 5.1% increase from the current price of $12.85. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates as a business development company, specializing in direct lending through senior, unitranche, mezzanine debt, and equity investments. It generates revenue by offering tailored financing solutions that support business expansions, acquisitions, and refinancings, enabling mid-sized enterprises to access capital that traditional banks may overlook.
The highest price target for BCSF is $15.00 from Paul Johnson at Keefe, Bruyette & Woods, which represents a 16.7% increase from the current price of $12.85.
The lowest price target for BCSF is $13.00 from Finian O'Shea at Wells Fargo, which represents a 1.2% increase from the current price of $12.85.
The overall analyst consensus for BCSF is neutral. Out of 3 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $13.50.
Stock price projections, including those for Bain Capital Specialty Finance Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.